Basic science for the clinician 39 -: NF-κB -: Function, activation, control, and consequences

被引:40
作者
Sigal, Leonard H.
机构
[1] Bristol Myers Squibb, Pharmaceut Res Inst, Princeton, NJ 08543 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Rheumatol & Connect Tissue Res, New Brunswick, NJ USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08903 USA
[5] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, New Brunswick, NJ 08903 USA
关键词
NF-kappa B; Rel; I kappa B; IKK; apoptosis;
D O I
10.1097/01.rhu.0000231385.94784.e4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Were there to be a crossroads through which all inflammatory signaling passed, controlling that junction would provide the ultimate therapeutic target for rheumatoid arthritis and many, if not all, autoimmune diseases. It now seems likely that no single cytokine or cytokine family represents such a crucial nexus. However, there is reason to believe that there may be an intracellular bottleneck that does: the family of NF-kappa B proteins. This family of proteins allows cytokine-receptor signals to enter the nucleus and either enhance or suppress the transcription of many genes involved in inflammation and in cellular survival itself. The same set of proteins is also involved in apoptosis and likely in carcinogenesis. The delicate choreography of control systems, balancing the effects of NF-kappa B proteins on the multiple DNA sites that are targeted, is also a prime target for specific therapies. Moreover, the NF-kappa B system interdigitates with other intracellular systems, eg, kinases, ubiquitin-associated protein degradation, that are critical to the normal function of cells, involved in homeostasis and inflammation, in autoimmune diseases and malignancy.
引用
收藏
页码:207 / 211
页数:5
相关论文
共 12 条
[1]   The two NF-κB activation pathways and their role in innate and adaptive immunity [J].
Bonizzi, G ;
Karin, M .
TRENDS IN IMMUNOLOGY, 2004, 25 (06) :280-288
[2]   NF-κB signaling:: Many roads lead to Madrid [J].
Dixit, V ;
Mak, TW .
CELL, 2002, 111 (05) :615-619
[3]   NF-κB:: Holy grail for rheumatoid arthritis? [J].
Firestein, GS .
ARTHRITIS AND RHEUMATISM, 2004, 50 (08) :2381-2386
[4]   Missing pieces in the NF-κB puzzle [J].
Ghosh, S ;
Karin, M .
CELL, 2002, 109 :S81-S96
[5]   NF-κB at the crossroads of life and death [J].
Karin, M ;
Lin, A .
NATURE IMMUNOLOGY, 2002, 3 (03) :221-227
[6]   Signal transduction in rheumatoid arthritis [J].
Sweeney, SE ;
Firestein, GS .
CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (03) :231-237
[7]   Host-pathogen interactions:: Subversion and utilization of the NF-κB pathway during infection [J].
Tato, CM ;
Hunter, CA .
INFECTION AND IMMUNITY, 2002, 70 (07) :3311-3317
[8]   TCR-induced NF-κB activation:: a crucial role for Carma1, Bcl10 and MALT1 [J].
Thome, M ;
Tschopp, J .
TRENDS IN IMMUNOLOGY, 2003, 24 (08) :419-424
[9]   Decoding NF-κB signaling [J].
Ting, AY ;
Endy, D .
SCIENCE, 2002, 298 (5596) :1189-1190
[10]   Phosphorylation of NF-κB and IκB proteins:: implications in cancer and inflammation [J].
Viatour, P ;
Merville, MP ;
Bours, V ;
Chariot, A .
TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (01) :43-52